$250K
Awamu za ufadhili wa startup za Bioteknolojia
Awamu mpya za ufadhili wa startup kutoka nyaraka za Form D za SEC na habari za teknolojia. Awamu zinazofuatiliwa: 296. Imesasishwa 15 Okt 2026.
Tazama zote 2,236Akili bandia na data 200Mawakala wa AI 30Miundombinu ya AI 11Akili bandia 191Data na uchanganuzi 10Programu za B2B 1,130Usalama wa mtandao 25Miundombinu ya wingu 25Tija 9Mauzo na masoko 5Teknolojia ya HR 8Teknolojia ya sheria 9Fintech 168Malipo 10Benki na mikopo 80Uwekezaji 6Bima 53Kripto na Web3 6Uhasibu na fedha 7Afya 558Afya ya kidijitali 15Vifaa vya matibabu 28Ustawi na afya ya akili 15Teknolojia ya kina 360Roboti 38Uzalishaji viwandani 125Anga za juu na ulinzi 26Tabianchi na nishati 117Usafirishaji na ugavi 10Usafiri na magari 11Chakula na kilimo 35Majengo na ujenzi 18IoT na mawasiliano 13Watumiaji na biashara 79Biashara mtandaoni 34Mitandao ya kijamii 5Michezo ya video 5Habari na burudani 13Elimu 9Safari na utalii 8
$500KDebt
$55MEquity
$1.25MDebt
InSitu Biologics
Form D: zimeuzwa $1.25M kati ya $3.38M zilizotolewa · Wawekezaji: 1 · waraka uliorekebishwa
$2.96MEquity
Hypercell Technologies
Form D: zimeuzwa $2.96M kati ya $4.42M zilizotolewa · Wawekezaji: 14
$7.5MOptions
$1.01MEquity
$1.23MEquity
$49.8MEquity + debt
Curadel Surgical Innovations
Form D: zimeuzwa $49.8M kati ya $57.5M zilizotolewa · Wawekezaji: 39
$66.1KEquity
$560KDebt
$2.63MEquity
$185KDebt
€16MSeed
Undecimal Bio
Undecimal Bio lands €16 million to develop targeted RNA medicines beyond the liver
$1.2MEquity + debt
$3MEquity
$167KEquity
$20M
Polyphron
Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials
$1.2MDebt
$4.35MEquity
GelSana Therapeutics
Form D: zimeuzwa $4.35M kati ya $4.93M zilizotolewa · Wawekezaji: 33 · waraka uliorekebishwa
$10.1MEquity
$1.5MEquity
$388KEquity
Rheos Medical
Form D: zimeuzwa $388K kati ya $2M zilizotolewa · Wawekezaji: 9 · waraka uliorekebishwa
$388KEquity
$100KEquity
$7MEquity
$233KEquity
€3.8MSeed
Cori Clinical
London’s Cori Clinical raises €3.8 million to accelerate clinical trials and reduce delays
$75MSeries B
Multiply Labs
Multiply Labs raises $75M to optimize pharmaceutical manufacturing with robots
$3.32MEquity + debt
$200KSAFE
€23.2MSeries B
WhiteLab Genomics
Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development
$8.97MOptions
$16.1MEquity
Eikonoklastes Therapeutics
Form D: zimeuzwa $16.1M kati ya $18.6M zilizotolewa · Wawekezaji: 15 · waraka uliorekebishwa
$35.1MEquity
$900KEquity
$2.5MSAFE
$15.7MEquity
Altay Therapeutics
Form D: zimeuzwa $15.7M kati ya $45.1M zilizotolewa · Wawekezaji: 19
$100KOptions
$352MEquity